Concepedia

Paul D. Crowe

PD

Statistics

Publications

54

Citations

4.5K

H-Index

32

Active since

1988

Affiliations

Neurocrine Biosciences (United States)(Current)

University of California, Riverside

University of South Florida

Orphagen Pharmaceuticals (United States)

Japan Tobacco (Japan)

Paul D. Crowe is an author at Neurocrine Biosciences (United States) specializing in life sciences, pharmacology, and cell signaling.

Publications per year

1988–2019

54

Publications

54

The performance prism in practice

Andy Neely, Chris Adams, Paul D. Crowe · Measuring Business Excellence · 2001 · 644 citations

, , +17

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

Ludwig Kappos, Giancarlo Comi, Hillel Panitch et al. · Nature Medicine · 2000 · 514 citations

, , +17

A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.

Paul D. Crowe, Barbara Walter, K M Mohler et al. · The Journal of Experimental Medicine · 1995 · 232 citations · Full text

, , +13

A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin

David G. Alleva, Paul D. Crowe, Liping Jin et al. · Journal of Clinical Investigation · 2001 · 210 citations · Full text

, , +16

Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells

Carl F. Ware, Paul D. Crowe, M H Grayson et al. · The Journal of Immunology · 1992 · 183 citations · Full text

, , +10

1–5 of 54